Community and academic medical oncologists, hematologists, advanced practitioners (NP/PA, PharmD), and other clinicians who treat patients with CLL
After participating in the activity, participants should be better able to
An application has been made to the UEMS EACCME® for CME accreditation of this event.
It is the policy of Bio Ascend, LLC to ensure balance, independence, objectivity, and scientific rigor in all Bio Ascend, LLC events. All individuals planning/developing content are expected to disclose to the learners all relevant financial relationships prior to the beginning of the continuing education (CE) activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services influence practice and/or patient recommendations. Bio Ascend, LLC must identify and resolve any potential conflict of interest prior to activity development and disclosure of these relationships will be included in all event materials so that participants may formulate their own judgments in interpreting content and in evaluating recommendations. Failure or refusal to provide disclosure information will prohibit anyone from presenting at/or participating in the planning of this activity.
This faculty may discuss unlabeled or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for approved indications, contraindications, and warnings.
Participants have a responsibility to use newly acquired information to improve their practice and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management; primary references, relevant practice guidelines, and full prescribing information should be consulted